Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.99%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.03%
#4 clBTC clBTC +12.26%
#5 OpenEden OpenEden +10.90%
#6 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.95%
#7 MarsCoin MarsCoin +8.78%
#8 Mantle Staked Ether Mantle Staked Ether +8.43%
#9 Mantle Restaked ETH Mantle Restaked ETH +8.23%
#10 Akedo Akedo +8.03%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Classificação em ações #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Preço da ação
$0.00162013
Última sincronização: 2025-01-03
Valor de mercado
$156.25K
Variação (1 dia)
0.36%
Variação (1 ano)
0.00%
País
SE
Negociar Cyxone AB (publ) (CYXO)

Categoria

Healthcare
Rácio P/B de Cyxone AB (publ) (CYXO)
Rácio P/B em August 2026 TTM: 0.05
De acordo com os relatórios financeiros mais recentes e o preço das ações da Cyxone AB (publ), o rácio P/B atual (TTM) é 0.05. No final de 2022, o rácio P/B era 0.95.
Histórico do rácio P/B da Cyxone AB (publ) de 2015 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) 0.05 -80.68%
2023 0.25 -73.81%
2022 0.95 -62.04%
2021 2.50 -27.47%
2020 3.45 49.69%
2019 2.31 74.16%
2018 1.32 -75.84%
2017 5.48 22.16%
2016 4.49 -98.16%
2015 243.41 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 12,863.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 13,043.48%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 7,423.81%
BE